Systematic Anticoagulation Management (SAM)
SAM is a patient-focused approach to anticoagulation management that utilizes PT/INR testing at the point of care rather than through an outside lab.
Multiple studies have shown that a systematic approach to anticoagulation management, focused at the point of care, may increase the time patients on warfarin therapy are in range, reduce adverse events, improve patient satisfaction, and lower the costs of care.1,2,3,4,5
The SAM Advisor Program is an educational resource from Roche Diagnostics designed to help healthcare professionals learn more about point-of-care PT/INR testing and the most effective ways to implement systematic anticoagulation management in their practice
The program consists of three components:
|
Connections
|
Peer-to-peer information exchange with leading clinicians in the field. |
|
Resources
|
Reference tools to provide clinical knowledge and offer insights to help facilitate SAM implementation. |
|
Solutions
|
Products and other support to facilitate easy, accurate PT/INR testing at the point of care. |
For more information on systematic anticoagulation management or the SAM Advisor Program contact your Roche Diagnostics account manager.
For information on additional anticoagulation management topics, please visit our Related Links page.
1 Campbell P, Radensky P, Denham C. Economic analysis of systematic anticoagulation management vs. routine medical care for patients on oral warfarin therapy.
Disease Management and Clinical Outcomes, 2000;2.
Economic analysis of cost impact of systematic anticoagulation management vs. routine medical care for 1000 atrial fibrillation patients on warfarin therapy.
2 Jacobson A, Guilloteau F, Campbell P, Denham C. Comparison of point-of-care testing and standard reference laboratory testing for PT/INR measurements in patients receiving routine warfarin therapy: an engineering work process flow study.
Disease Management and Clinical Outcomes, 2000;2.
Comparison of prospective analysis of workflow and operational costs of PT/INR testing and retrospective analysis of the utilization of anticoagulation management strategies for two point of care clinics and two control clinics that used standard reference laboratories.
3 Wurster M, Doran T. Anticoagulation management: A new approach.
Disease Management, 2006;4:201-209.
4 Ansell JE, Buttaro ML, Thomas OV, et al., and the Anticoagulation Guidelines Task Force. Consensus guidelines for coordinated outpatient oral anticoagulation therapy management.
Ann Pharmacother. 1997;31:604-615
5 Singer DF. Anticoagulation for atrial fibrillation: Epidemiology informing a difficult clinical decision.
Proc Assoc Am Physicians. 1996:8(1):29-36
